Residency · Stanford, CA
Sponsored by Stanford Health Care
Type 2 immunity in allergic diseases.
Cellular & molecular immunology · 2025 · 297 citations · Kari Nadeau
Multiple early factors anticipate post-acute COVID-19 sequelae.
Cell · 2022 · 907 citations · Scott Boyd
Omalizumab for the Treatment of Multiple Food Allergies.
The New England journal of medicine · 2024 · 270 citations · Sayantani Sindher, Sharon Chinthrajah
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper.
Allergy · 2023 · 222 citations · Kari Nadeau
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease.
Allergy · 2022 · 334 citations · Kari Nadeau
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
Nature immunology · 2022 · 426 citations · Kari Nadeau
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Lancet (London, England) · 2022 · 283 citations · Kari Nadeau, Sharon Chinthrajah, Sayantani Sindher
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update).
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021 · 288 citations · Kari Nadeau